Relationship of Cytokeratin 20 and CD44 Protein Expression with WHO/ISUP Grade in pTa and pT1 Papillary Urothelial Neoplasia
Authors:
- 1 December 2000
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 13 (12) , 1315-1323
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Focal Loss of CD44 Variant Protein Expression is Related to Recurrence in Superficial Bladder CarcinomaThe American Journal of Pathology, 1999
- The World Health Organization/International Society of Urological Pathology Consensus Classification of Urothelial (Transitional Cell) Neoplasms of the Urinary BladderAmerican Journal of Surgical Pathology, 1998
- CD44 and the adhesion of neoplastic cells.Molecular Pathology, 1997
- Cytokeratin 20 as an objective marker of urothelial dysplasiaBritish Journal of Urology, 1996
- Unusual retention of introns in CD44 gene transcripts in bladder cancer provides new diagnostic and clinical oncological opportunitiesThe Journal of Pathology, 1995
- Cytokeratin 20 expression by non‐invasive transitional cell carcinomas: potential for distinguishing recurrent from non‐recurrent diseaseHistopathology, 1995
- Cytokeratin 20 Is a General Marker of Cutaneous Merkel Cells While Certain Neuronal Proteins Are AbsentJournal of Investigative Dermatology, 1995
- The hyaluronate receptor is preferentially expressed on proliferating epithelial cells.Journal of Cell Biology, 1989
- Recurrence, Progression and Survival in Bladder CancerScandinavian Journal of Urology and Nephrology, 1987
- EPIDERMAL-GROWTH-FACTOR RECEPTORS IN HUMAN BLADDER CANCER: COMPARISON OF INVASIVE AND SUPERFICIAL TUMOURSThe Lancet, 1985